CROs/Service Providers

HGS refuses GSK unsolicited offer, considers alternatives

Friday, April 20, 2012 11:21 AM

Human Genome Sciences has refused GlaxoSmithKline’s unsolicited offer on April 11 proposing to acquire all of the outstanding shares of HGS for $13.00 per share in cash ($2.6 billion), an 81% premium to closing share price on April 18.

More... »

INC Research, Astellas form multi-year development alliance

Wednesday, April 18, 2012 11:04 AM

INC Research, a therapeutically focused CRO, has entered into a Functional Service Provider (FSP) alliance with Astellas Pharma to drive global consistency, save time and reduce costs for multiple clinical development programs across several therapeutic areas.

More... »

AMRI and Biota strike development and manufacturing deal

Wednesday, April 18, 2012 09:44 AM

AMRI, a global contract research and manufacturing organization, was selected by Biota Holdings, an Australian anti-infective drug development company, to further develop and manufacture influenza antiviral CS8958 (laninamivir), a second-generation, long-acting neuraminidase inhibitor.

More... »

MDI completes $1.9M Series B financing for Detect-Ready tests

Tuesday, April 17, 2012 07:30 AM

Molecular Detection Inc. (MDI), a Berwyn, Penn.-based company developing Detect-Ready tests designed to increase the speed and accuracy of infectious disease diagnosis, has completed a $1.9 million Series B recapitalization financing. 

More... »

BASF and Catalent aim to solve bioavailability challenges

Friday, April 6, 2012 12:36 PM

Catalent Pharma Solutions, a services and solutions provider, and BASF, a leading chemical company, have formed an open alliance to provide solutions to overcome bioavailability challenges of new molecular entities with solubility or permeability challenges. 

More... »

Covidien to acquire Oridion Systems

Friday, April 6, 2012 11:22 AM

Covidien, a global healthcare products company, will be acquiring Jerusalem-based Oridion Systems, creator of Microstream etCO₂ monitoring and sampling technologies.

More... »

Charles River and Metabolon partner on cancer research

Friday, April 6, 2012 10:54 AM

Charles River Discovery Services is partnering with Metabolon, a diagnostic products and services company based in Research Triangle Park, N.C., to enhance oncology research.

More... »

MPI Research, Edge partner on brain hemorrhage therapies

Friday, April 6, 2012 09:57 AM

MPI Research, the world’s largest single-site preclinical CRO, and Edge Therapeutics, a hospital-focused biopharmaceutical company, will collaborate on preclinical and clinical testing of Edge's lead product candidates to advance life-saving therapies after brain hemorrhaging.

More... »

GE Healthcare acquires SeqWright, boosts Clarient unit

Wednesday, April 4, 2012 03:01 PM

GE Healthcare has acquired SeqWright, a provider of nucleic acid sequencing and other genomic services, adding complementary genomics capabilities to Clarient, a molecular diagnostics GE unit.

More... »

Burrill wraps up life sciences industry for Q1 2012

Wednesday, April 4, 2012 03:00 PM

Burrill & Company, a diversified global financial services firm focused on the life sciences industry, has identified more than $2.6 billion in expected funding through nine translational research and early-stage initiatives announced since the end of February.

More... »